Market Research Reports Global Retinal Drugs Market Report 2019 | Page 2

Increasing health education initiatives about eye diseases to seek early treatment and prevent visual
impairment in emerging regions are further anticipated to fuel the expansion of the global market for
Retinal Drugs during the forecast period.
According to Regional Analysis, North America is expected to account for a significant share of the
market in terms of revenue. High research and development activities in the field of ophthalmic drugs,
rising patient population, and high disposable income are factors which are attributed to the high
market share of the region.
Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has
approved EYLEA (aflibercept) Injection to treat all stages of diabetic retinopathy (DR), and thereby
reduce the risk of blindness.
Novartis announced a new data analysis showing that retinal fluid was detected less often in patients
treated with brolucizumab (RTH258) 6 mg versus aflibercept over four visits between weeks 36 to 48[1].
Retinal fluid is a key marker of disease activity in neovascular age-related macular degeneration (nAMD).
Retinal Drugs Market Covers the Table of Contents With Segments, Key Players And Region. Based on
Product Type, Retinal Drugs Market is sub segmented into Wet AMD, Diabetic Retinopathy, DME, RVO,
Mcnv. On the Basis of Application, Market is sub segmented into Hospital and Clinic.
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on
“Global Retinal Drugs MarketReport 2019” https://www.businessindustryreports.com/buy-
now/160380/single .
MajorPlayers profiled in the Retinal Drugs Market report incorporate: Bayer, F. Hoffmann-La Roche,
Novartis, Regeneron, Merck, Shire, Teva Pharmaceutical, ThromboGenics
Region segment: This report is segmented into several key regions, with sales, revenue, market share
(%) and growth Rate (%) of Retinal Drugs in these regions, from 2014 to 2023 (forecast), covering: North
America, Europe, Asia Pacific, Middle East & Africa and South America.
The report is a compilation of first-hand information, qualitative and quantitative assessment by
industry analysts, inputs from industry experts and industry participants across the value chain. The
report provides in-depth analysis of parent market trends, macro-economic indicators and governing
factors along with market attractiveness as per segments. The report also maps the qualitative impact of
various market factors on market segments and geographies.
Significant points in table of contents: Market Definition, Market Overview, Business Introduction,
Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation
(Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost
Analysis, and Conclusion.
Report contents include